The interview delves into various aspects of vaccine development, including the impact of COVID-19 on vaccine technology, the significance of mRNA vaccines, and the challenges and opportunities in vaccine development during a pandemic. Additionally, it explores the evolution of vaccine technology, the importance of international recognition for vaccines, and the role of political and professional motivations in healthcare. Throughout the discussion, the CEO provides insights into Adimmune's vaccine development efforts, their collaboration with international partners, and their strategies for addressing emerging health challenges.